Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jan
29
2015
Brazil Mailbox Litigation Update: Good News to Start the Year for the Pharmaceutical Industry Michael Best & Friedrich LLP
Jul
23
2015
The Riddle Wrapped in a Mystery Inside an Enigma – the Federal Circuit decides Amgen v. Sandoz – is anyone happy? Michael Best & Friedrich LLP
Aug
31
2015
An Update on Biosimilar Activity in the U.S. Michael Best & Friedrich LLP
Nov
22
2015
Trans-Pacific Partnership and the Continuing Controversy Over the Exclusivity Period for Biologics Michael Best & Friedrich LLP
Mar
9
2017
Green Groups Petition EPA to Overhaul CAFO Regulations Michael Best & Friedrich LLP
Jul
16
2013
Ethanol and Other Biomass Plants No Longer Exempt from Carbon Dioxide Emission Limits: D.C. Circuit Vacates EPA's Three-Year Deferral for Biogenic CO2 Sources Michael Best & Friedrich LLP
Aug
2
2013
Healthcare and Data Exclusivity in Russia – One Year Later Michael Best & Friedrich LLP
Jul
1
2014
Nanotechnology in Food Production: FDA Finalizes Guidance on Manufacturing Process Changes for Food Additives Michael Best & Friedrich LLP
Sep
22
2014
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 1 of a 5-Part Series Michael Best & Friedrich LLP
Jan
3
2015
FDA’s Second Swing at Proposed FSMA regulations Michael Best & Friedrich LLP
Jan
21
2015
Teva Pharmaceuticals v. Sandoz: Supreme Court Changes Standard of Review in Claim Construction Case Michael Best & Friedrich LLP
Jun
30
2015
AstraZeneca’s Crestor® Patent is Invalidated by the Brazilian Federal Courts Michael Best & Friedrich LLP
Nov
11
2010
Revised Biomass Crop Assistance Program Begins Michael Best & Friedrich LLP
Aug
10
2011
Commercial Biopharma in Wisconsin: What Next? Michael Best & Friedrich LLP
May
19
2012
JOBS Act Update for Biofuels Companies Michael Best & Friedrich LLP
Apr
23
2013
Know Your Rights When the Environmental Protection Agency (EPA) Comes Knocking Michael Best & Friedrich LLP
Jul
9
2013
Seventh Circuit Determines That Failing to Obtain a Prevention of Significant Deterioration (PSD) Permit is a One-Time Violation of the Clean Air Act Michael Best & Friedrich LLP
Aug
9
2013
Recent Decisions involving Section 3(d) of the Indian Patents Act Michael Best & Friedrich LLP
Feb
25
2014
Angels and Early Exits: Sometimes, a Bird in the Bush is Worth More than a Bird in the Hand Michael Best & Friedrich LLP
Jun
13
2014
Supreme Court Rules that Competitors Can Challenge Advertising that is False or Misleading Even if it Complies with Federal Food and Beverage Labeling Laws Michael Best & Friedrich LLP
Jun
7
2015
Brazil’s New Biodiversity Law Michael Best & Friedrich LLP
May
5
2016
FDA Issues Deeming Rule regarding Tobacco Products Michael Best & Friedrich LLP
Jul
6
2016
Federal Circuit Rules Biosimilar Notice of Commercial Marketing Mandatory Michael Best & Friedrich LLP
Aug
19
2016
FDA Issues Final Rule on Substances Generally Recognized as Safe Michael Best & Friedrich LLP
Mar
12
2011
The USDA Accepting Applications for Biobased Product Label Michael Best & Friedrich LLP
Apr
18
2011
USDA Announces Funding for Blender Pumps Michael Best & Friedrich LLP
Jul
20
2013
Supplementary Protection Certificates and Pediatric Extensions in Croatia Michael Best & Friedrich LLP
Mar
31
2014
EPA (Environmental Protection Agency) Releases Proposed Rule to Clarify Its Jurisdiction Under the Clean Water Act Michael Best & Friedrich LLP
Jul
30
2014
The Race is on! Anxiously Waiting for the First U.S. Biosimilar to Cross the Finish Line Michael Best & Friedrich LLP
Nov
20
2014
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 Michael Best & Friedrich LLP
Nov
28
2014
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 3 of a 5-Part Series Michael Best & Friedrich LLP
Jun
7
2015
Federal Circuit Hears Oral Arguments in Litigation involving the First U.S. Biosimilar Product Michael Best & Friedrich LLP
Jan
8
2016
January 8, 2016 -- Biologics and Biosimilars Bits and Bytes Michael Best & Friedrich LLP
Apr
26
2017
New Guidelines in Brazil Give More Power to ANVISA in Examination of Pharmaceutical Patent Applications Michael Best & Friedrich LLP
Nov
13
2010
USPTO Extends and Expands the Green Technology Pilot Program Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins